systemic monograph lidocaine also known lignocaine sold brand name xylocaine among others local anesthetic amino amide type also used treat ventricular used local anaesthesia nerve blocks lidocaine typically begins working within several minutes lasts half hour three lidocaine mixtures may also applied directly skin mucous membranes numb often used mixed small amount adrenaline epinephrine prolong local effects decrease injected intravenously may cause cerebral effects confusion changes vision numbness tingling cause low blood pressure irregular heart concerns injecting joint cause problems appears generally safe use lower dose may required liver generally safe use allergic tetracaine lidocaine antiarrhythmic medication class ib means works blocking sodium channels thus decreasing rate contractions injected near nerves nerves conduct signals lidocaine discovered went sale world health organizations list essential available generic commonly prescribed medication united states thousand efficacy profile lidocaine local anaesthetic characterized rapid onset action intermediate duration efficacy therefore lidocaine suitable infiltration block surface anaesthesia longeracting substances bupivacaine sometimes given preference spinal epidural anaesthesias lidocaine though advantage rapid onset action adrenaline vasoconstricts arteries reducing bleeding also delaying resorption lidocaine almost doubling duration anaesthesiacitation needed lidocaine one commonly used local anaesthetics dentistry administered multiple ways often nerve block infiltration depending type treatment carried area mouth worked surface anaesthesia several formulations used endoscopies intubations etc lidocaine drops used eyes short ophthalmic procedures tentative evidence topical lidocaine neuropathic pain skin graft donor site local numbing agent used treatment premature adhesive transdermal patch containing concentration lidocaine hydrogel bandage approved us fda reducing nerve pain caused transdermal patch also used pain causes compressed nerves persistent nerve pain surgeries lidocaine also important antiarrhythmic drug used intravenously treatment ventricular arrhythmias acute myocardial infarction digoxin poisoning cardioversion cardiac catheterization amiodarone available contraindicated lidocaine given indication defibrillation cpr vasopressors initiated routine preventive dose longer recommended myocardial infarction overall benefit review treatment neonatal seizures recommended intravenous lidocaine secondline treatment phenobarbital fails stop intravenous lidocaine infusions also used treat chronic pain acute surgical pain opiate sparing technique quality evidence use poor difficult compare placebo inhaled lidocaine used cough suppressor acting peripherally reduce cough reflex application implemented safety comfort measure patients intubated reduces incidence coughing tracheal damage might cause emerging systematic review literature found intraurethral lidocaine reduces pain men undergo cystoscopic lidocaine along ethanol ammonia acetic acid may also help treating jellyfish stings numbing affected area preventing nematocyst gastritis drinking viscous lidocaine formulation may help adverse drug reactions adrs rare lidocaine used local anesthetic administered correctly adrs associated lidocaine anesthesia relate administration technique resulting systemic exposure pharmacological effects anesthesia allergic reactions rarely systemic exposure excessive quantities lidocaine mainly result central nervous system cns cardiovascular effects cns effects usually occur lower blood plasma concentrations additional cardiovascular effects present higher concentrations though cardiovascular collapse may also occur low concentrations adrs system adrs associated use intravenous lidocaine similar toxic effects systemic exposure doserelated frequent high infusion rates mgmin common adrs include headache dizziness drowsiness confusion visual disturbances tinnitus tremor andor paraesthesia infrequent adrs associated use lidocaine include hypotension bradycardia arrhythmias cardiac arrest muscle twitching seizures coma andor respiratory generally safe use lidocaine vasoconstrictor adrenaline including regions nose ears fingers concerns tissue death used areas raised evidence support use lidocaine spinal anesthesia may lead increased risk transient neurological symptoms painful condition sometimes experienced immediately weak evidence suggest use alternative anesthetic medications prilocaine procaine bupivacaine ropivacaine levobupivacaine may decrease risk person developing transient neurological low quality evidence suggests mepivacaine used spinal anesthetic similar risk person developing transient neurological symptoms drugs also ligands potentially increase serum levels potential toxicity decrease serum levels efficacy depending whether induce inhibit enzymes respectively drugs may increase chance methemoglobinemia also considered carefully dronedarone liposomal morphine absolutely contraindication may increase serum levels hundreds drugs require monitoring absolute contraindications use lidocaine include exercise caution patients overdoses lidocaine may result excessive administration topical parenteral routes accidental oral ingestion topical preparations children susceptible overdose accidental intravenous rather subcutaneous intrathecal paracervical injection prolonged use subcutaneous infiltration anesthesia cosmetic surgerycitation needed overdoses often led severe toxicity death children adults local anesthetic systemic symptoms include central nervous system manifestations numbness tongue dizziness tinnitus visual disturbances convulsions reduced consciousness progressing coma well respiratory arrest cardiovascular lidocaine two major metabolites may quantified blood plasma serum confirm diagnosis potential poisoning victims assist forensic investigation case fatal overdosecitation needed lidocaine often given intravenously antiarrhythmic agent critical cardiaccare treatment intravenous lipid emulsions used parenteral feeding reverse effects local anaesthetic toxicity becoming lidocaine large amounts may toxic cartilage intraarticular infusions lead postarthroscopic glenohumeral lidocaine alters signal conduction neurons prolonging inactivation fast voltagegated na channels neuronal cell membrane responsible action potential sufficient blockage voltagegated sodium channels open action potential generated careful titration allows high degree selectivity blockage sensory neurons whereas higher concentrations also affect types neuronscitation needed principle applies drugs actions heart blocking sodium channels conduction system well muscle cells heart raises depolarization threshold making heart less likely initiate conduct early action potentials may cause used injectable typically begins working within four minutes lasts half hour three lidocaine metabolized dealkylated liver mainly pharmacologically active metabolites monoethylglycinexylidide megx subsequently inactive glycine xylidide megx longer halflife lidocaine also less potent sodium channel volume distribution lkg lkg congestive heart failure decrease circulates bound protein acid glycoprotein oral bioavailability topical bioavailability elimination halflife lidocaine biphasic around min min patients may prolonged patients hepatic impairment average min congestive heart failure average lidocaine excreted urine metabolites unchanged heart lidocaines molecular structure lies lipophilic group featuring core contributing molecules hydrophobic characteristics addition aromatic unit lidocaine incorporates aliphatic section comprising amide carbonyl enyl groups multifaceted arrangement endows molecule unique properties capacity interact biological systems lidocaine exhibits remarkable degree conformational flexibility resulting probable adaptability arises high lability amide ethyl groups within molecule groups undergo shifts positions leading significant variations overall molecular configuration dynamic transformation lidocaine conformers supercritical carbon dioxide highly depends external factors alterations conditions lead distinct conformations impacting molecules physicochemical properties one notable consequence variations particle size lidocaine produced micronization using changes position amide group within molecule trigger redistribution intra intermolecular hydrogen bonds affecting outcome micronization process resultant particle lidocaine first amino local anesthetic previous amino esters first synthesized name xylocaine swedish chemist nils l√∂fgren colleague bengt lundqvist performed first injection anesthesia experiments first marketed lidocaine usually form hydrochloride salt available various forms including many topical formulations solutions injection also available transdermal patch applied directly skincitation needed lidocaine hydrochloride epinephrine solution injection cartridge lidocaine hydrochloride solution injection topical lidocaine spray viscous lidocaine lidocaine international nonproprietary name inn british approved name ban australian approved name lignocaine former bancitation needed aan old new names displayed product label australia least xylocaine brand name referring major synthetic builing block ligno prefix chosen xylo means wood greek ligno means latin lido prefix instead refers fact drug chemically related lidocaine listed world antidoping agency substance whose use banned used adjuvant adulterant diluent street drugs cocaine one three common ingredients site enhancement oil used lidocaine often added cocaine cocaine lidocaine numb gums applied gives user impression highquality cocaine actuality user receiving diluted component veterinary drug tributame along embutramide chloroquine used carry euthanasia horses httpsenwikipediaorgwikilidocaine